JoseAntonioStouteMDFACP, FIDSA

PubMed

• 686 citations
  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
  José A. Stoute, Moncef Mohamed Slaoui, D. G. Heppner, P Momin, Kent E. Kester
  The New England Journal of Medicine. 1997-01-09
• 20 citations
  Distinct pattern of class and subclass antibodies in immune complexes of children with cerebral malaria and severe malarial anaemia.
  Erick K. Mibei, Walter Otieno, Alloys S. S. Orago, José A. Stoute
  Parasite Immunology. 2008-06-01
• 191 citations
  Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria
  Christian F. Ockenhouse, Pei Fang Sun, David E. Lanar, Bruce T. Wellde, B. Ted Hall
  The Journal of Infectious Diseases. 1998-06-01

Journal Articles

• Plasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes.  
  Awandare GA, Spadafora C, Moch JK, Dutta S, Haynes JD, Stoute JA, Mol.Biochem.Parasitol
• Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocks.  
  Bull PC, Buckee CO, Kyes S, Kortok MM, Thathy V, Guyah B, Stoute JA, Newbold CI, and Marsh K, Mol Microbiol
• Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.  
  Odhiambo CO, Otieno W, Adhiambo C, Odera MM, Stoute JA, BMC
• Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adul...  
  Stoute JA, Gombe J, Withers MR, Siangla J, McKinney D, Onyango M, Cummings JF, Milman J, Tucker K, Soisson L, et al., Vaccine
• Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.  
  Withers MR, McKinney D, Ogutu BR, Waitumbi JN, Milman JB, Apollo OJ, Allen OG, Tucker K, Soisson LA, Diggs C, Leach A, Wittes J, Dubovsky F, Stewart V A, Remich S A, C..., PLoS.Clin Trials
• Immune complex levels in children with severe Plasmodium falciparum malaria.  
  Mibei EK, Orago AS, Stoute JA., Am.J.Trop.Med.Hyg.
• Complement-regulatory proteins in severe malaria: too little or too much of a good thing?  
  Stoute JA, Trends Parasitol.
• Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya.  
  Thathy V, Moulds JM, Guyah B, Otieno W, Stoute JA, Malar.J
• The risk of hypersensitivity reactions as a function of the CD4 count in HIV-infected patients.  
  Morikawa S, Cortese L, Walker J, Oster C, Stoute J, Journal of Pharmacy Technology
• The battalion medical platoon: a flawed scalpel.  
  Cannon MW, Stoute JA, Mil.Med
• Minimal change glomerulonephropathy and interstitial infiltration with mycosis fungoides.  
  Allon M, Campbell WG, Jr., Nasr SA, Bourke E, Stoute J, Guntupalli J., Am.J.Med
• HMG-proteins 1 and 2 are required for transcription of chromatin by endogenous RNA polymerase.  
  Stoute JA, Marzluff WF, Biochem.Biophys.Res.Commun
• Join now to see all

Books/Book Chapters

• Gonococcemia. 
  Stoute JAEditors: Heymann WR, Anderson BE, Hivnor C, Lessin S (eds) Clinical.Decision Support in Medicine, LLC, Wilmington, DE
• American Trypanosomiasis. 
  Stoute JAEditors: Heymann WR, Anderson BE, Hivnor C, Lessin S (eds) Clinical.Decision Support in Medicine, LLC, Wilmington, DE

Lectures

• Novel Model of Severe Malarial Anemia: Where Are All the Red Cells Going? 
  Division of Malaria Vaccine Research, Walter Army Institute of Research, Silver Spring, MD
• Complement and Antibody-mediated enhancement of red cell invasion by Plasmodium falciparum. 
  Gordon Research Conference, Red Cells